BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Kremezin (AST-120) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Kremezin (AST-120)\, from ClinicalTrials.
 gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07182422-893@assetmemo.bio
DTSTAMP:20261121T005640Z
DTSTART;VALUE=DATE:20270211
DTEND;VALUE=DATE:20270212
SUMMARY:Kremezin (AST-120): Phase 4 readout est. (NCT07182422)
DESCRIPTION:Kremezin (AST-120)\, phase 4.\nStudy: AST-120 (Kremezin®) for 
 the Renal Protection and Attenuation of Decline in Acute Kidney Disease\nE
 stimated primary completion: 11 February 2027. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/ast-120#upcoming-events\nRegistry record: https:
 //clinicaltrials.gov/study/NCT07182422
URL:https://assetmemo.bio/drug/ast-120#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
